Chief Scientist
React4life, Liguria, Italy
She received in 2005 the Ph.D. in Bioengineering at the University of Genoa, Italy.
Since 2010 Silvia Scaglione is permanent Researcher at National council of Research (CNR).
She is founder and chief scientist of React4life s.r.l., an innovative biotech company that develops organ on chip technologies for accelerating the human disease understanding and novel personalized therapies development; React4life has won several international awards and projects, such as H2020 SME Instrument Phase 1, seal of Excellence SME phase 2, Innovation Radar (2021) as best Health technology.
Scaglione is author of more than 80 international peer-reviewed papers, book chapters, author of 7 patents.
Scaglione is currently the coordinator of a Future Emerging Technology (FET-OPEN) H2020 project, entitled “Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity -B2B”.
Disclosure information not submitted.
Monday, February 7, 2022
5:50 PM – 6:00 PM
Wednesday, February 9, 2022
10:00 AM – 11:00 AM